Health

Results: 4693-4704 of 9325

CKGSB and Johns Hopkins University Launch AI-Driven Healthcare Innovation Program

Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars

UPM's Board of Directors has approved the commencement of a new plan for the period 2025-2027 within the Performance Share Arrangement

The LetsGetChecked ImPress is only for use with compatible collection and transport devices that are cleared for use with this device. It is not intended for use as a blood collection kit. This device is not intended for at-home collection or collection by a lay user. Tube image is for illustrative purposes only. (Photo: Business Wire)

LetsGetChecked ImPress Lancing Device Receives FDA 510K Clearance

PR Newswire associated0

Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches

Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea

PR Newswire associated0

Michel Lussier Joins Caristo Diagnostics Board of Directors

Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

PR Newswire associated0

VIVOZON Pharmaceutical Obtains MFDS Approval for UNAFRA Inj.: A Breakthrough Non-Opioid analgesic

Leqembi® sales reaches €200 million - first sales milestone achieved

PR Newswire associated0

CJ Bioscience to Present Preclinical Data on Inflammatory Bowel Disease Pipeline Candidate CJRB-201 at 'ECCO 2025'; Clinical Entry Targeted for 2026